ZURA

Zura Bio (ZURA)

About Zura Bio (ZURA)

Zura Bio Ltd. is a clinical-stage, multi-asset immunology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Details

Daily high

$3.80

Daily low

$3.58

Price at open

$3.59

52 Week High

$7.44

52 Week Low

$1.00

Market cap

351.5M

Dividend yield

0.00%

Volume

472,161

Avg. volume

940,346

P/E ratio

-3.03

Zura Bio News